Home » Reports » Broker Ratings » AstraZeneca plc 20.4% Potential Decrease Indicated by Goldman Sachs
Analyst Broker Ratings

AstraZeneca plc 20.4% Potential Decrease Indicated by Goldman Sachs

AstraZeneca plc using EPIC/TICKER code (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘SELL’ this morning by analysts at Goldman Sachs. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Goldman Sachs have set a target price of 5000 GBX on its stock. This would indicate that the analyst believes there is a downside of -20.4% from today’s opening price of 6283 GBX. Over the last 30 and 90 trading days the company share price has increased 602 points and increased 142 points respectively. The 1 year high for the stock price is 6432.48 GBX while the year low stock price is currently 4746 GBX.

AstraZeneca plc has a 50 day moving average of 5,913.00 GBX and a 200 day moving average of 5,848.42. There are currently 1,267,287,658 shares in issue with the average daily volume traded being 2,316,417. Market capitalisation for LON:AZN is £79,750,412,317 GBP.